Micro Laryngeal Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Micro laryngeal surgery (MLS), also termed microlaryngoscopy, is an endoscopic surgical technique that uses a rigid suspension laryngoscope and an operating microscope to provide magnified, binocular visualisation of the larynx — enabling precise diagnosis and surgical treatment of a wide range of laryngeal pathologies. The procedure is performed under general anaesthesia with the patient supine and the neck extended in the 'sniffing position'.

The modern technique was pioneered by Kleinsasser in the 1960s, combining a modified direct laryngoscope held in suspension (via a chest support or Martin arm attached to the operating table) with the Carl Zeiss OPMI surgical microscope (typically providing 6–25x magnification). This hands-free configuration gives the surgeon complete bimanual instrument control at high magnification, fundamentally transforming laryngeal surgery from a crude blind procedure to one of the most precision-demanding operations in surgical practice.

Airway management during MLS requires careful anaesthetic planning: options include jet ventilation (subglottic or supraglottic), tubeless spontaneously ventilating techniques, or laser-safe endotracheal intubation (using small-diameter or laser-resistant tubes). The choice depends on the surgical site, laser use, and patient anatomy.

MLS addresses the full spectrum of benign and malignant laryngeal pathology:

Benign Vocal Cord Lesions

• Vocal cord nodules: Bilateral symmetric lesions at the junction of the anterior and middle thirds of the vocal cords; caused by vocal overuse or misuse. Primarily treated by voice therapy; surgery reserved for persistent nodules after adequate voice therapy (minimum 3 months). Cold steel microsurgical dissection preserving the superficial lamina propria (SLP) is essential.
• Vocal cord polyps: Typically unilateral, pedunculated or sessile; haemorrhagic or translucent. Surgical excision by cold steel microsurgical technique or KTP laser. The SLP must be meticulously preserved to maintain vocal cord vibratory mechanics.
• Vocal cord cysts (epidermoid and mucous retention): Intracordal cysts; require complete enucleation with an intact capsule to prevent recurrence. Underlying epithelium is preserved where possible.
• Vocal cord granuloma: Contact granulomata, typically arising from the posterior vocal cord/vocal process of the arytenoid; most often caused by intubation trauma or laryngopharyngeal reflux (LPR). KTP or CO2 laser excision; mandatory post-operative LPR treatment (PPI + lifestyle) and voice therapy to prevent recurrence.
• Reinke's oedema (polypoid corditis): Bilateral gelatinous subepithelial oedema of the SLP; strongly associated with smoking. Microflap technique — incision along the superior surface, aspiration of gelatinous material, preservation of epithelium — with bilateral staged procedures if needed.
• Laryngeal papillomatosis (RRP — Recurrent Respiratory Papillomatosis): Caused by human papillomavirus (HPV) subtypes 6 (low-grade) and 11 (high-grade, more aggressive). Presents in juvenile onset (usually <5 years) and adult onset forms. Characterised by recurrent exophytic lesions predominantly on the true vocal cords, supraglottis, and subglottis. Treatment requires repeated surgical debulking — CO2 laser, KTP laser, or microdebrider. The KTP 532 nm laser selectively targets haemoglobin in papilloma blood vessels and has largely replaced CO2 laser in specialist centres for RRP due to superior SLP preservation. Adjuvant therapies for aggressive RRP include bevacizumab (anti-VEGF) intralesional injections and cidofovir; the HPV 9-valent vaccine (Gardasil 9) prevents new HPV 6/11 infection.
• Subglottic and posterior glottic stenosis: Acquired (intubation-related) or idiopathic; managed by microlaryngoscopic CO2 laser incisions (radial incisions), balloon dilatation, or combined endoscopic approaches. Cotton–Myer classification guides management.

Laryngeal Cancer (Glottic Carcinoma)

Transoral laser microsurgery (TLM) is an organ-preservation endoscopic approach developed at Hannover Medical School by Wolfgang Steiner. It offers oncologically equivalent cure rates to open partial laryngectomy or radiotherapy for early (T1–T2) glottic squamous cell carcinoma while preserving the larynx and — when performed with precision — maintaining near-normal voice function.

• Steiner classification: TLM resection is guided by the Steiner-Hannover classification, which permits resection through the tumour in multiple pieces (piecemeal resection) to achieve adequate oncological margins — a paradigm distinct from en-bloc open surgery.
• Remacle ELS Cordectomy Classification (European Laryngological Society): Standardises endoscopic cordectomy extent for glottic cancer: Type I (subepithelial), Type II (subligamental), Type III (transmuscular), Type IV (total cordectomy), Type Va (extended to anterior commissure), Type Vb (extended to contralateral cord), Type Vc (extended to arytenoid), Type Vd (extended to subglottis), Type VI (total and extended total cordectomy). Each type corresponds to tumour invasion depth (Tis, T1a, T1b, T2).
• CO2 laser technique for TLM: The CO2 laser (10,600 nm wavelength) is delivered via micromanipulator attached to the operating microscope; it provides simultaneous cutting and haemostasis. Critical tissue precision (<0.5 mm thermal spread with superpulse or ultrapulse modes) allows tumour resection with clear histological margins. Frozen-section margin assessment may be performed intraoperatively.
• Anterior commissure disease: Technically demanding; risk of anterior web formation post-resection. Web prevention strategies include lateral placement of mucosal edges, keel placement (laryngofissure approach needed for severe cases), or use of mitomycin-C.

Patient suitability for microlaryngoscopy depends on both clinical and anatomical factors:

• Clinical indications: Dysphonia (voice change) persisting >3 weeks despite voice therapy (for benign lesions), stridor (for airway compromise), suspected laryngeal malignancy, diagnostic laryngoscopy for unclear laryngeal lesions, surveillance in known RRP, therapeutic procedures.
• Laryngoscopic access assessment: Prior to MLS, the surgeon must assess whether the larynx can be adequately exposed under direct suspension laryngoscopy. Risk factors for difficult laryngoscopy include limited mouth opening (<3.5 cm), prominent upper teeth, short or muscular neck, obesity (BMI >35), cervical spine immobility, and mandibular prominence. Flexible nasolaryngoscopy in clinic is mandatory for all patients.
• Laser safety contraindications: If CO2 laser is planned, a laser-safe airway technique (subglottic jet ventilation, tubeless anaesthesia, or laser-resistant endotracheal tube) must be used. All staff wear wavelength-specific safety eyewear; the patient's eyes and teeth are protected with moist swabs.
• For glottic cancer: TLM eligibility requires endoscopic tumour accessibility, absence of posterior commissure invasion (for bilateral cases), no gross cartilage invasion (T4 disease), and patient suitability for general anaesthesia. CT/MRI of the larynx and neck is performed pre-operatively. PET-CT for T2 and above.
• Voice concerns: Pre-operative voice assessment (laryngostroboscopy, acoustic analysis, voice handicap index VHI-10, VRQOL) provides a baseline and informs surgical approach to maximise voice preservation.

Suspension Laryngoscopy Setup

The Kleinsasser laryngoscope is introduced under direct vision along the tongue towards the epiglottis, then advanced to expose the larynx. Once optimally positioned, it is suspended using a chest support or Martin arm — freeing both the surgeon's hands for bimanual microsurgical instrumentation. The Carl Zeiss OPMI microscope (or equivalent — Leica M520, Storz VITOM 3D) is then brought into the operating field, typically at 400 mm focal length, providing 6–25x magnification and coaxial illumination.

Instrument Categories

• Cold steel microsurgery: Using 0.3–1.0 mm micro-cup forceps, micro-scissors, sickle knives, and needle-tipped dissectors specific to laryngeal microsurgery sets (Kleinsasser, Storz). Cold steel offers maximum tactile feedback, no thermal injury to the SLP, and is preferred for vocal cord nodules, polyps, and cysts where SLP preservation is paramount.
• CO2 laser: Wavelength 10,600 nm; absorbed by water in tissues; delivered via a micromanipulator (Acuspot, AcuBlade) attached to the operating microscope. Provides simultaneous cutting and haemostasis. Superpulse and ultrapulse modes minimise thermal lateral spread (<200–500 microns), allowing precision resection. Standard for TLM in glottic cancer, subglottic stenosis incisions, RRP debulking.
• KTP (potassium titanyl phosphate) laser — 532 nm: Green light selectively absorbed by oxyhaemoglobin; excellent haemostasis with very limited thermal spread. Delivered via flexible fibre through the operative channel of a rigid laryngoscope (without microscope) or via fibre holder under microscope control. Preferred for RRP, vascular lesions, and granulomata. The 532 nm PDL (pulsed dye laser) is a closely related technology.
• Coblation: Radiofrequency-based plasma-mediated ablation at low temperatures (~40–70°C); reduces thermal injury. Used in some units for RRP and glottic lesions.
• Microdebrider: Rapidly rotating blade with simultaneous suction for soft tissue debridement. Used in some centres for RRP bulk reduction.

Superficial Lamina Propria (SLP) Preservation

The SLP — Reinke's space — is the viscoelastic layer immediately deep to the squamous epithelium of the true vocal cord. It is essential for normal mucosal wave propagation during phonation. All microsurgical techniques targeting benign vocal cord lesions must preserve the SLP to maintain voice quality. The 'microflap technique' involves raising an epithelial microflap lateral to the lesion, carefully dissecting within the SLP to remove the lesion, and replacing the microflap — preserving the vibratory layer.

Anterior Commissure and Web Prevention

Bilateral or anterior commissure lesions risk post-operative anterior glottic web formation from denuded opposing mucosal surfaces. Prevention strategies: stage bilateral procedures (6–8 weeks apart), use of mitomycin-C (topical antifibrotic, applied for 4 minutes post-resection), or intralaryngeal keel placement in severe cases requiring formal anterior commissure reconstruction.

• Precision: Operating microscope magnification (6–25x) allows identification and preservation of tissue layers invisible to the naked eye — including the critical superficial lamina propria of the vocal cords.
• Organ and voice preservation: For early glottic cancer (T1a, T1b), TLM achieves oncological cure while preserving the larynx and maintaining functional voice in the majority of patients — avoiding the morbidity of total laryngectomy or the extended treatment course of radiotherapy.
• Minimal access: Entirely endoscopic (transoral) — no external incisions, no tracheotomy in most cases, no visible scarring, rapid recovery (outpatient or 1-night stay).
• Simultaneous diagnosis and treatment: Microlaryngoscopy enables biopsy under direct visualisation followed immediately by definitive excision in a single anaesthetic in many benign lesions and selected malignant cases.
• Haemostasis: CO2 and KTP lasers provide excellent intraoperative haemostasis in a confined, poorly accessible surgical field where conventional ties and sutures are impractical.
• RRP management: Repeated surgical control of RRP maintains airway patency and voice quality between recurrences; targeted KTP or CO2 laser minimises scarring while effectively debulking papillomatous tissue.
• Rapid recovery: Most benign vocal cord procedures allow discharge the same day; voice rest for 3–7 days followed by voice therapy. Return to work: 1–2 weeks for most occupations.

• Dental and lip injury: The Kleinsasser laryngoscope rests on the upper teeth during suspension — dental guard is essential. Upper lip bruising or laceration can occur if unprotected. Prior dental assessment is recommended for patients with crowns, bridges, or implants.
• Difficult laryngoscopy / inadequate exposure: In 3–5% of patients, adequate laryngeal exposure cannot be achieved under suspension laryngoscopy. In these cases, the procedure must be abandoned or converted to an alternative approach (e.g., videolaryngoscopy-guided or external approach).
• Anterior glottic web: Most significant long-term complication of bilateral anterior vocal cord procedures; causes dysphonia and may require revision surgery or keel placement.
• Dysphonia / voice deterioration: Injury to the SLP during excision causes vocal cord scarring — the most significant cause of permanent voice impairment after benign vocal cord surgery. Experienced laryngeal surgeons with SLP-preserving technique minimise this risk.
• Haemorrhage: Rare with laser techniques; more likely with cold steel in vascular polyps. Usually managed intraoperatively.
• Airway fire: The most feared complication of laser laryngoscopy — ignition of endotracheal tube or drapes in an oxygen-enriched environment. Prevention: laser-safe airway, FiO2 <0.3, moist swabs protecting surrounding structures, strict team laser protocol (WHO laser safety checklist), vigilance with all ignition sources.
• Recurrence: RRP inevitably recurs after surgical debulking; adjuvant systemic therapies (bevacizumab, cidofovir) may extend disease-free intervals. Benign lesions (polyps, cysts) have low recurrence with complete excision; nodules recur if vocal behaviour is not modified.
• Subglottic stenosis: CO2 laser resection near the subglottis risks circumferential scarring and progressive airway narrowing months after surgery.
• Anaesthetic risks: Jet ventilation carries risk of barotrauma (pneumothorax, surgical emphysema). Standard intubation limits surgical access. Careful joint planning between surgeon and anaesthetist is essential.

Immediate Post-Operative Period

• Airway monitoring: Most patients are observed for 2–4 hours post-procedure for airway oedema. Dexamethasone 8 mg IV intraoperatively and/or humidified oxygen post-operatively reduces oedema risk.
• Voice rest: Strict vocal rest (no vocalisation, including whispering — which creates greater vocal cord tension than normal speech) for 3–7 days, depending on extent of procedure. Written communication, text messaging, or voice amplifiers are used during voice rest. Whispering is specifically contraindicated.
• Analgesia: Paracetamol and low-dose ibuprofen (if not contraindicated). Avoid aspirin (antiplatelet effect increases bleeding risk).
• Laryngopharyngeal reflux (LPR) management: Proton pump inhibitor (omeprazole 40 mg twice daily) for a minimum of 3 months post-operatively, particularly for granulomata and Reinke's oedema, where LPR is a major cofactor in pathogenesis and recurrence.

Outpatient Follow-Up

• Flexible nasolaryngoscopy at 4–6 weeks: To assess healing, mucosal wave return (stroboscopy), and presence of residual or recurrent pathology.
• Voice therapy: Referral to a specialist laryngologist-led speech and language therapist (SLT) is standard practice for all benign vocal cord lesions — both to address pre-existing vocal habits contributing to the lesion and to optimise voice rehabilitation post-surgery.
• For glottic cancer (TLM): Rigid or flexible laryngostroboscopy at 6 weeks, 3 months, 6 months, then 6-monthly for 5 years. MRI or CT of the larynx and neck if clinical concern for recurrence. Involvement in a multidisciplinary head and neck team is mandatory.
• For RRP: Surveillance intervals guided by disease burden and recurrence rate — typically every 6–12 weeks for active disease, extending to 3–6 months for controlled disease. Annual pulmonary function tests for patients with pulmonary extension.
• Smoking cessation: Strongly encouraged for all patients; smoking delays mucosal healing, promotes LPR, and is a major risk factor for laryngeal carcinoma recurrence and Reinke's oedema progression.

Micro laryngeal surgery costs vary by procedure complexity, energy source, and healthcare system:

• India (private hospitals): Diagnostic microlaryngoscopy with biopsy: INR 20,000–50,000. Microlaryngoscopy with vocal cord polyp/cyst excision (cold steel or KTP laser): INR 40,000–80,000. CO2 laser TLM for early glottic cancer: INR 1,00,000–2,50,000 in tertiary centres. Available at government medical colleges (AIIMS, PGI Chandigarh) at substantially subsidised rates.
• UK (NHS): Available through ENT and head and neck surgical units in NHS teaching hospitals. Wait times may apply for benign lesions; cancer patients are seen under the 2-week-wait cancer pathway. All treatment is free at point of care for eligible patients.
• UK (private): Microlaryngoscopy for benign vocal cord lesion: £3,000–6,000 (anaesthetic, surgeon, hospital facility fees). CO2 TLM for glottic cancer: £8,000–15,000 depending on complexity and hospital.
• Additional cost factors: Laser-specific instrumentation (CO2 laser systems: capital cost £80,000–200,000; annual maintenance significant) concentrates TLM services in specialist tertiary centres. KTP laser-fibre disposables add approximately £500–800 per case. Stroboscopy and laryngological voice assessment: INR 3,000–8,000 in India; included in NHS bundle.
• Medical tourism: India, Thailand, and Turkey offer MLS procedures — including laser procedures for RRP and early glottic cancer — at 20–40% of European/US equivalent costs. Specialist laryngology expertise and infrastructure is concentrated in major metropolitan centres.

• Voice therapy alone: Appropriate first-line management for vocal nodules, muscle tension dysphonia, and functional dysphonia. A minimum of 3 months of specialist speech and language therapy should precede surgical decision-making for benign lesions in most patients.
• Office-based laryngeal procedures (awake, transnasal): Flexible fibre-based KTP or PDL laser can be delivered transnasally via flexible laryngoscope under topical anaesthesia in cooperative patients — avoiding general anaesthesia. Suitable for vocal cord granulomata, small polyps, and RRP lesions in patients with high anaesthetic risk. Increasingly available in specialist laryngology centres.
• Radiotherapy for glottic cancer: External beam radiotherapy (EBRT) achieves equivalent local control rates to TLM for T1a glottic squamous cell carcinoma (~90–95% 5-year local control). It preserves voice quality comparably in T1 disease. Preferred when TLM access is limited or by patient choice. Disadvantages: 6–7 weeks of daily treatment, acute and late radiation mucosal toxicity, radiation-induced chondroradionecrosis (rare), and larynx fibrosis risk.
• Bevacizumab (anti-VEGF) for RRP: Intravenous bevacizumab reduces recurrence rates and extends surgical intervals in patients with aggressive RRP. Used as adjuvant to surgery, not replacement.
• HPV vaccination: Gardasil 9 (9-valent HPV vaccine) provides protection against HPV 6 and 11 — the causative subtypes of RRP. Vaccination of children before sexual debut is the only preventive strategy. Recommended in national vaccination programmes globally.
• Open laryngeal surgery: Frontolateral hemilaryngectomy, vertical partial laryngectomy, and supracricoid laryngectomy for cancers not amenable to endoscopic resection. Associated with greater morbidity than TLM but remains appropriate for selected patients with limited TLM access or advanced T2 disease with deep invasion.